Zydus Lifesciences US arm bags USFDA nod for generic version of Mirabegron ER tablets Ruchika Sharma3 Oct 2022 6:45 AM GMTMirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and urinary frequency.
Lupin bags USFDA approval for Mirabegron ER tablets to treat overactive bladder Ruchika Sharma30 Sep 2022 5:58 AM GMTThe product will be manufactured at Lupin's facility in Nagpur, India.
